Call: 631.543.3334

Gemini Pharmaceuticals Inc. Names Chief Operating Officer

For Immediate Release

mark-smallCommack, NY, August 26, 2015 – Gemini Pharmaceuticals Inc., a global manufacturer of specialty pharmaceuticals, Over the Counter (OTC) pharmaceuticals, and dietary and nutritional supplements for the past 30 years, announces the appointment of Mark J. Gaeta as the Chief Operating Officer.

Mark has over 35 years’ experience in the pharmaceutical and dietary supplement industries. His background includes the design, construction oversight, and subsequent start-up management of facilities for a number of pharmaceutical and nutritional companies. This includes one of the first facilities cGMP certified within the NNFA program which, upon completion, was named Nutritional Outlook’s Manufacturer of the Year. Additionally, Mark played a key role in the rehabilitation of several generic pharmaceutical companies.

He previously has held executive and senior leadership positions including Chief Operating and Quality Officer, COO, VP Manufacturing, VP Planning and Administration, Director Engineering and Plant Engineer at large supplement and pharmaceutical (both ethical and generic) companies.

Mark has served on the Government Relations Committee for AHPA as well as the Quality Group for NPA (formally NNFA) and made significant contributions to the NPA GMP program. He has lectured at several Universities and government agencies on topics ranging from cGMP, Quality Control and Quality Assurance, Environmental Compliance, and Air and Water Pollution Abatement.  

“We are very excited to have Mark as a member of our Gemini team. His unsurpassed experience and success in our core businesses, as well as his familiarity with Gemini and our current organization, will be essential in helping us manage the next stages of our tremendous growth. Additionally, Mark will be a key driver of improvements to our quality and operational systems, allowing Gemini to expand its current product offerings and services to our diverse customer base both within the US and around the world” offers Mike Finamore, CEO of Gemini Pharmaceuticals Inc.

About Gemini Pharmaceuticals Inc.:

Gemini Pharmaceuticals Inc. is a global manufacturer of dietary and nutritional supplements, specialty pharmaceuticals, and Over the Counter (OTC) pharmaceuticals. With over 30 years of experience, Gemini has grown to be a world class manufacturer of solid dosage product with production exceeding 18 billion tablets / capsules per year. The quality of the operation has been recognized by the achievement of both NSF and TGA registrations and the issuance of a Foreign Site Reference Number by Health Canada. Gemini also produces products in compliance with both Kosher and Halal requirements.

Media Contact: Mark Jost, 631-543-3334; mjost@geminipharm.com

Comments are closed.